GENNEX LABORATORIES LTD. Share Price

₹ 8.21

+₹0.19 (2.37%)
1D
Last updated 02 Nov, 2026, 15:52 IST
BSE: 531739
|
Pharmaceuticals

GENNEX LABORATORIES LTD. Share Price Today

As of 2 Nov 2026, GENNEX LABORATORIES LTD. share price is ₹8.21. The stock opened at ₹8.02, compared to its previous close of ₹8.02. During today's trading session, GENNEX LABORATORIES LTD. share price moved in the range of ₹7.99 to ₹8.44, with an average price of ₹8.21 for the day. Looking at its last 52-week, the stock has touched a low of ₹7.05 and a high of ₹16.99.

Share price over the last 1 day rose from 8.06 to 8.25, ranging between 8.06 and 8.39.
₹7.99
2.37% up today
₹8.44
1D LOW
1D HIGH

GENNEX LABORATORIES LTD. Stock Insights

Latest Earning
Op Profit TrendUp by 5.35% QoQ
Latest Earning
Net Profit TrendUp by 4.71% QoQ
Latest Earning
Revenue TrendUp by 14.00% YoY
Stock Performance
UnderperformingUnderperforming Nifty by 37.6 % in last 1 yr
GENNEX LABORATORIES LTD. stock performance
Open₹8.02
High₹8.44
Low₹7.99
Prev. close₹8.02
GENNEX LABORATORIES LTD. trading activity
Volume10,53,207
Average traded price₹8.16
Last traded time03:52:50 02 Nov
Last traded quantity250
Circuit
L
H
₹6.42
₹9.62
52-week
L
H
₹7.05
₹16.99
Mkt Cap Cr
194.84
P/E
9.44
P/B
0.88
ROA
5.92%
ROE
8.29%
ROCE
9.09%
Quick Ratio
2.91
EV/EBITDA
6.13

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Gennex Lab. has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Gennex Lab. appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Gennex Lab. revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

GENNEX LABORATORIES LTD. Company Background

ISIN
INE509C01026
Sector Market Cap
₹ 194.84 Cr

Gennex Laboratories Limited is an India-based active pharmaceutical ingredient manufacturing company. The Company is engaged in the business of manufacturing of bulk drugs and intermediaries. It offers products in various therapeutic categories, including expectorant (mucolyte), relaxant (skeletal muscle relaxant), antihistamines, urinary tract analgesic, antifungals called triazoles, tricyclic antidepressant, acting muscle relaxants, muscle relaxant, selective serotonin reuptake inhibitors (SSRIS), and xanthine oxidase inhibitors. Its products include Guaifenesin, Methocarbamol, Fexofenadine Hcl, Phenazopyridine Hcl, Fluconazole, Melitracen Hcl, Mephenesin, Chlorphenesin, Sertraline Hcl and Allopurinol. The Company has manufacturing facilities in India which cater to both domestic and international markets. Its international markets include Bangladesh, Bolivia, China, Colombia, Costa Rica, Cuba, Germany, Indonesia, Iran, Iraq, Israel, Jordan, Kenya, South Korea, Malaysia and Mexico.

GENNEX LABORATORIES LTD. Financial Highlights

  • Revenue: GENNEX LABORATORIES LTD. reported revenue of ₹180.99 crore in FY26 vs ₹158.76 crore in FY25. It showed an increase of 14.00% on a yearly basis.
  • Operating Profit: GENNEX LABORATORIES LTD. reported an operating profit of ₹23.24 crore in FY26 vs ₹21.40 crore in FY25. It showed an increase of 8.60% on a year-on-year basis.
  • Net Profit: GENNEX LABORATORIES LTD. reported a net profit of ₹20.98 crore in FY26 vs ₹18.12 crore in FY25. It showed an increase of 15.78% on a yearly basis.

GENNEX LABORATORIES LTD. Quarterly Result Highlights

  • GENNEX LABORATORIES LTD. reported revenue of ₹41.85 crore in Jun 2026, compared with ₹62.28 crore in Mar 2026, representing a decrease of 32.80% on a quarter-on-quarter (QoQ) basis.
  • GENNEX LABORATORIES LTD. reported an operating profit of ₹4.92 crore in Jun 2026, compared with ₹4.67 crore in Mar 2026, representing an increase of 5.35% on a quarter-on-quarter (QoQ) basis.
  • GENNEX LABORATORIES LTD. reported a profit of ₹4.67 crore in Jun 2026, compared with ₹4.46 crore in Mar 2026, reflecting an increase of 4.71% on a QoQ basis.
  • The earnings per share (EPS) of GENNEX LABORATORIES LTD. stood at ₹0.87 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
23.63%
FII
0.00%
Other DII
0.00%
Retail and other
76.37%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Sep 20260.00%

GENNEX LABORATORIES LTD. Investment Returns

1 day
-10.49%
1 week
-7.82%
1 month
-19.40%
1 year
-51.16%
3 years
-27.68%
5 years
+14.08%

GENNEX LABORATORIES LTD. Share Price History

GENNEX LABORATORIES LTD. share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
30 Oct 26
₹8.91 / ₹8.02
-10.49%
29 Oct 26
₹9.20 / ₹8.96
-1.54%
28 Oct 26
₹8.80 / ₹9.10
+2.48%
27 Oct 26
₹8.65 / ₹8.88
+3.38%
Show more

GENNEX LABORATORIES LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹172.74₹137.90₹86.71₹65.60
Other Income₹8.25₹10.43₹4.91₹3.95
Total Revenue₹180.99₹148.33₹91.62₹69.56
Total Expenses₹157.15₹126.79₹75.13₹63.18
Profit Before Tax₹23.24₹21.40₹16.49₹6.37
Tax₹2.26₹3.27₹3.32₹1.45
Profit After Tax₹20.98₹18.12₹13.18₹4.92
EPS - Basic₹0.87₹1.26₹0.67₹0.32
EPS - Diluted₹0.87₹1.26₹0.61₹0.32

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹23.29₹21.40₹16.49₹6.37
Income before WC changes₹23.00₹13.05₹18.14₹5.98
Change in Assets-₹86.50-₹13.43-₹66.88₹5.25
Change in Liabilities₹2.11-₹6.21₹2.05₹12.45
Change in WC-₹84.39-₹19.64-₹64.83₹17.69
Cash flow from Operations-₹63.65-₹9.56-₹46.69₹23.68
Cash flow from Investing-₹4.80₹2.63₹18.91-₹38.33
Cash flow from Financing₹65.30₹1.53₹73.68₹21.03
Total Cash Flow-₹3.15-₹5.40₹45.91₹6.38
Cash (Start of the year)₹55.57₹60.96₹15.06₹8.68
Cash (End of the year)₹52.42₹55.56₹60.98₹15.06

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹84.02₹74.91₹68.17₹83.63
Current Assets₹264.66₹181.13₹161.81₹48.68
Total Assets₹348.68₹256.04₹229.99₹132.32
Current Liabilities₹72.40₹44.56₹40.30₹29.51
Net Current Asset₹192.26₹136.57₹121.51₹19.17
Non-Current Liabilities₹43.44₹16.89₹13.22₹16.29
Equity Capital₹232.84₹194.59₹176.46₹86.52
Total Equity & Liabilities₹348.68₹256.04₹229.99₹132.32

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹119.86₹94.58₹66.80₹65.10
Other Income₹8.14₹9.22₹4.30₹3.40
Total Revenue₹128.00₹103.80₹71.10₹68.50
Total Expenses₹109.16₹86.59₹56.35₹62.49
Profit Before Tax₹18.24₹17.06₹14.75₹6.01
Tax₹2.11₹3.02₹2.96₹1.45
Profit After Tax₹16.13₹14.04₹11.80₹4.56
EPS - Basic₹0.66₹0.62₹0.69₹0.31
EPS - Diluted₹0.66₹0.62₹0.69₹0.31

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹18.29₹17.06₹14.87₹6.01
Income before WC changes₹14.59₹11.02₹13.06₹5.28
Change in Assets-₹54.05-₹13.43-₹60.48-₹19.00
Change in Liabilities₹1.39-₹7.11₹15.08-₹0.72
Change in WC-₹52.66-₹20.54-₹45.40-₹19.73
Cash flow from Operations-₹40.18-₹9.52-₹33.43-₹14.45
Cash flow from Investing₹1.62₹2.63₹0.93-₹0.77
Cash flow from Financing₹35.40₹1.53₹79.01₹21.35
Total Cash Flow-₹3.16-₹5.36₹46.51₹6.14
Cash (Start of the year)₹55.60₹60.96₹14.45₹8.31
Cash (End of the year)₹52.44₹55.60₹60.96₹14.45

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹35.73₹31.36₹26.35₹24.06
Current Assets₹238.09₹187.02₹178.99₹72.16
Total Assets₹273.82₹218.38₹205.34₹96.22
Current Liabilities₹52.08₹29.11₹32.82₹15.91
Net Current Asset₹186.01₹157.91₹146.17₹56.25
Non-Current Liabilities₹3.62₹4.47₹1.76₹1.29
Equity Capital₹218.12₹184.80₹170.76₹79.02
Total Equity & Liabilities₹273.82₹218.38₹205.34₹96.22
* All values are in INR Crore
GENNEX LABORATORIES LTD. market depth
Bid quantityBid priceAsk priceAsk quantity
166478.2500
3698.2100
0000
0000
0000
Total bid quantity17,016
Total ask quantity0
GENNEX LABORATORIES LTD. technical summary
Bearish indicators3
Neutral indicators3
Bullish indicators2
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
26.46
Bearish
ATR (14)
0.56
Neutral
STOCH(9,6)
21.19
Neutral
STOCH RSI (14)
10.73
Bullish
ADX(9)
54.26
Bearish
UO(9)
37.95
Neutral
ROC(12)
-12.92
Bearish
WillR(14)
-85.39
Bullish
Period
Simple value
Exponential vaue
5D
8.71
8.63
10D
8.8
8.83
20D
9.22
9.19
50D
10.46
9.8
100D
10.15
10.11
Volume trend — traded volume by day
2 Nov10L
30 Oct13L
29 Oct1L
28 Oct2L
27 Oct2L
26 Oct2L
Average5L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

GENNEX LABORATORIES LTD.
Pharmaceuticals
Add Stock
Add Another

GENNEX LABORATORIES LTD. Returns Calculator

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

GENNEX LABORATORIES LTD. Share Price FAQs

Please be aware that GENNEX LABORATORIES LTD. stock prices are subject to continuous fluctuations due to various factors.